Viatris-Theramex Deal Under Scrutiny Amid Antitrust Concerns in the U.K.

Viatris-Theramex Women's Care Products Deal

The U.K.'s antitrust officials have expressed concerns over a deal that Viatris (VTRS) inked to sell rights for its women's care products to Theramex.

Antitrust Scrutiny in the U.K.

• The U.K.'s regulatory body is closely monitoring the implications of the deal.
• Theramex stands to benefit from acquiring the rights to Viatris' women's care products.
• However, potential antitrust issues could hinder the completion of the agreement.